Recently, the FDA approved a weight loss drug for the first time in 13 years. Qsymia, a combination of the appetite suppressant phentermine and the anticonvulsant drug topiramate, is being marketed towards obese patients and overweight patients with certain health concerns. While Dr. Feiz and his associates may eventually prescribe Qsymia, they question its efficacy especially when compared to a surgery like sleeve gastrectomy.
Now, those considering weight loss in Los Angeles wonder if this pill can take the place of bariatric surgery for those dangerously concerned about their health. As mentioned in our recent article, "Now It's Time for Science to Take a Crack at Weight Loss," Qsymia promises a 10% excess weight loss per year. This is good for any patient who needs to lose weight; however, it pales to the effects of gastric sleeve which Dr. Feiz estimates removes at least 70% excess weight loss. Also, many current prescriptions of drugs similar to those found in Qsymia are only prescribed temporarily, causing some to wonder what their long term effects are on weight loss. Nonetheless, both are about reclaiming one's health and if Qsymia happens to change lives for the better then it can be a powerful tool for surgeons like Dr. Feiz to better help their patients.
No comments:
Post a Comment